Mr. Chair, at that time, we were working with information provided by the company, Janssen. Subsequent to that statement, we received information on the specific site of manufacture of the drug substance in the Janssen vaccines and issued our statement.
As a consequence of the concerns accruing from the U.S. FDA report, we placed the drugs under quarantine upon their arrival in Canada on April 28.